Search

everythinglearnresearchcommunity

for

Search:↓

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

The document explains the genetic causes and characteristics of inherited hair disorders.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Hyaluronic acid and versican are important for skin healing and hair growth and might help in regenerative medicine.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Platelet Rich Plasma (PRP) treatment is safe and effective for hair growth in people with androgenic alopecia, and can also help treat bacterial infections.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

IGF-1 from human placenta helps hair grow.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The document concludes that skin and nail changes can indicate various underlying health conditions.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Treat hair loss with medicine, continue indefinitely.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Antibody treatments show promise for hair loss but need more research.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.